GNFTY
Genfit SA
Price Chart
No historical data available
Latest Quote
$8.95
+0.00 (+0.00%)
Current Price
| Previous Close | $8.95 |
| Open | $9.00 |
| Day High | $9.00 |
| Day Low | $8.80 |
| Volume | 1,608 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 50.04M |
| Total Debt | $161.90M |
| Cash Equivalents | $125.30M |
| Revenue | $52.59M |
| Net Income | $-45.17M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $457.74M |
| EPS (TTM) | $-0.90 |
| Exchange | PNK |
Recent Price History
No history data available. Data will be fetched automatically.
About Genfit SA
Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2a trial to treat patients with cholangiocarcinoma (CCA); VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia; CML-022; SRT-015, an ASK1 inhibitor targets the inhibition of cellular apoptosis, inflammation, and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.
đ° Latest News
No news articles available at the moment. Check back later for updates on GNFTY.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $300,000 | $341,000 | $251,000 | $162,000 |
| Cost Of Revenue | $300,000 | $341,000 | $251,000 | $162,000 |
| Total Revenue | $67,002,000 | $28,565,000 | $20,195,000 | $80,069,000 |
| Operating Revenue | $67,002,000 | $28,565,000 | $20,195,000 | $80,069,000 |
| Expenses | ||||
| Interest Expense | $4,747,000 | $4,624,000 | $4,410,000 | $4,955,000 |
| Total Expenses | $63,776,000 | $55,730,000 | $47,510,000 | $47,698,000 |
| Other Income Expense | $791,000 | $72,000 | $7,157,000 | $6,157,000 |
| Net Non Operating Interest Income Expense | $-2,170,000 | $-1,419,000 | $-3,676,000 | $30,944,000 |
| Total Other Finance Cost | $-791,000 | $-1,496,000 | $-597,000 | $-35,625,000 |
| Interest Expense Non Operating | $4,747,000 | $4,624,000 | $4,410,000 | $4,955,000 |
| Operating Expense | $63,476,000 | $55,389,000 | $47,259,000 | $47,536,000 |
| Other Operating Expenses | $7,038,000 | $307,000 | $3,880,000 | $3,572,000 |
| General And Administrative Expense | $8,716,000 | $8,042,000 | $7,337,000 | $8,162,000 |
| Selling And Marketing Expense | - | - | $992,000 | $1,539,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,507,000 | $-28,894,000 | $-23,719,000 | $67,259,000 |
| Net Interest Income | $-2,170,000 | $-1,419,000 | $-3,676,000 | $30,944,000 |
| Interest Income | $1,786,000 | $1,709,000 | $137,000 | $274,000 |
| Normalized Income | $861,544 | $-28,948,000 | $-30,840,931 | $61,298,300 |
| Net Income From Continuing And Discontinued Operation | $1,507,000 | $-28,894,000 | $-23,719,000 | $67,259,000 |
| Total Operating Income As Reported | $3,281,000 | $-26,580,000 | $-27,289,000 | $31,816,000 |
| Net Income Common Stockholders | $1,507,000 | $-28,894,000 | $-23,719,000 | $67,259,000 |
| Net Income | $1,507,000 | $-28,894,000 | $-23,719,000 | $67,259,000 |
| Net Income Including Noncontrolling Interests | $1,507,000 | $-28,894,000 | $-23,719,000 | $67,259,000 |
| Net Income Continuous Operations | $1,507,000 | $-28,894,000 | $-23,720,000 | $67,259,000 |
| Pretax Income | $1,847,000 | $-28,514,000 | $-23,836,000 | $69,474,000 |
| Special Income Charges | $56,000 | $586,000 | $27,000 | $-556,000 |
| Interest Income Non Operating | $1,786,000 | $1,709,000 | $137,000 | $274,000 |
| Operating Income | $3,226,000 | $-27,165,000 | $-27,315,000 | $32,371,000 |
| Depreciation Amortization Depletion Income Statement | $372,000 | $331,000 | $152,000 | $550,000 |
| Depreciation And Amortization In Income Statement | $372,000 | $331,000 | $152,000 | $550,000 |
| Gross Profit | $66,702,000 | $28,224,000 | $19,944,000 | $79,907,000 |
| Per Share | ||||
| Diluted EPS | $0.03 | $-0.58 | $-0.48 | $1.23 |
| Basic EPS | $0.03 | $-0.58 | $-0.48 | $1.51 |
| Other | ||||
| Tax Effect Of Unusual Items | $145,544 | $18,000 | $35,069 | $196,300 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $7,527,000 | $-22,308,000 | $-24,751,000 | $71,014,000 |
| Total Unusual Items | $791,000 | $72,000 | $7,157,000 | $6,157,000 |
| Total Unusual Items Excluding Goodwill | $791,000 | $72,000 | $7,157,000 | $6,157,000 |
| Reconciled Depreciation | $1,724,000 | $1,654,000 | $1,832,000 | $2,742,000 |
| EBITDA (Bullshit earnings) | $8,318,000 | $-22,236,000 | $-17,594,000 | $77,171,000 |
| EBIT | $6,594,000 | $-23,890,000 | $-19,426,000 | $74,429,000 |
| Diluted Average Shares | $50,233,333 | $49,817,241 | $49,414,583 | $54,682,114 |
| Basic Average Shares | $50,233,333 | $49,817,241 | $49,414,583 | $44,542,384 |
| Diluted NI Availto Com Stockholders | $1,507,000 | $-28,894,000 | $-23,719,000 | $67,259,000 |
| Tax Provision | $340,000 | $380,000 | $-116,000 | $2,215,000 |
| Gain On Sale Of Ppe | $56,000 | $81,000 | $16,000 | $-414,000 |
| Restructuring And Mergern Acquisition | $0 | $-505,000 | $-11,000 | $142,000 |
| Gain On Sale Of Security | $735,000 | $-514,000 | $7,130,000 | $6,713,000 |
| Research And Development | $47,350,000 | $46,709,000 | $35,890,000 | $35,252,000 |
| Selling General And Administration | $8,716,000 | $8,042,000 | $7,337,000 | $8,162,000 |
| Salaries And Wages | $8,716,000 | $8,042,000 | $7,337,000 | $8,162,000 |
| Minority Interests | - | - | $0 | $0 |
| Other Gand A | - | - | - | $161,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $21,225,000 | $19,189,000 | $50,571,000 | $118,923,000 |
| Total Assets | $151,424,000 | $173,872,000 | $215,540,000 | $281,720,000 |
| Total Non Current Assets | $58,659,000 | $60,758,000 | $57,081,000 | $13,623,000 |
| Other Non Current Assets | $-1,000 | $-1,000 | - | $1,000 |
| Non Current Prepaid Assets | $303,000 | $303,000 | - | $397,000 |
| Non Current Deferred Assets | $0 | $0 | $0 | $0 |
| Non Current Deferred Taxes Assets | $0 | $0 | $0 | $0 |
| Non Current Note Receivables | $524,000 | $472,000 | - | $388,000 |
| Non Current Accounts Receivable | $354,000 | $531,000 | - | $516,000 |
| Investmentin Financial Assets | $1,884,000 | $2,819,000 | $4,914,000 | $3,133,000 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $459,000 | $471,000 | - | - |
| Goodwill And Other Intangible Assets | $47,999,000 | $48,762,000 | $43,957,000 | $174,000 |
| Other Intangible Assets | $47,999,000 | $48,762,000 | $43,957,000 | $174,000 |
| Current Assets | $92,766,000 | $113,115,000 | $158,459,000 | $268,097,000 |
| Other Current Assets | $1,000 | $1,000 | $1,000 | - |
| Prepaid Assets | $3,409,000 | $2,615,000 | $1,998,000 | $2,101,000 |
| Inventory | $4,000 | $4,000 | $4,000 | $4,000 |
| Receivables | $7,564,000 | $32,707,000 | $15,906,000 | $7,236,000 |
| Other Receivables | $989,000 | $505,000 | $131,000 | $859,000 |
| Taxes Receivable | $4,435,000 | $13,676,000 | $12,587,000 | $6,320,000 |
| Accounts Receivable | $2,140,000 | $18,526,000 | $3,188,000 | $7,236,000 |
| Cash Cash Equivalents And Short Term Investments | $81,788,000 | $77,788,000 | $140,550,000 | $258,756,000 |
| Cash And Cash Equivalents | $81,788,000 | $77,788,000 | $136,000,000 | $258,756,000 |
| Cash Equivalents | $63,027,000 | $67,530,000 | $119,090,000 | $69,045,000 |
| Cash Financial | $18,761,000 | $10,258,000 | $16,910,000 | $189,711,000 |
| Debt | ||||
| Total Debt | $62,133,000 | $70,179,000 | $75,275,000 | $74,234,000 |
| Long Term Debt And Capital Lease Obligation | $5,552,000 | $62,253,000 | $70,195,000 | $72,047,000 |
| Long Term Debt | $1,637,000 | $57,445,000 | $64,668,000 | $66,067,000 |
| Current Debt And Capital Lease Obligation | $56,581,000 | $7,926,000 | $5,080,000 | $2,187,000 |
| Current Debt | $55,436,000 | $6,850,000 | $4,048,000 | $1,098,000 |
| Other Current Borrowings | $55,436,000 | $6,761,000 | $4,048,000 | $1,098,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $82,200,000 | $105,921,000 | $121,012,000 | $162,623,000 |
| Total Non Current Liabilities Net Minority Interest | $7,038,000 | $67,441,000 | $81,642,000 | $99,786,000 |
| Non Current Deferred Liabilities | $145,000 | $4,210,000 | $10,216,000 | $26,423,000 |
| Non Current Deferred Taxes Liabilities | $145,000 | $455,000 | $510,000 | $602,000 |
| Current Liabilities | $75,162,000 | $38,480,000 | $39,370,000 | $62,837,000 |
| Other Current Liabilities | $-1,000 | - | - | - |
| Current Deferred Liabilities | $0 | $11,692,000 | $14,479,000 | $14,298,000 |
| Payables And Accrued Expenses | $18,542,000 | $18,822,000 | $19,750,000 | $46,039,000 |
| Payables | $18,542,000 | $18,822,000 | $19,750,000 | $46,039,000 |
| Other Payable | $4,381,000 | $5,102,000 | $5,715,000 | $4,215,000 |
| Total Tax Payable | $724,000 | $3,272,000 | $5,422,000 | $29,520,000 |
| Accounts Payable | $13,437,000 | $10,448,000 | $8,613,000 | $12,304,000 |
| Tradeand Other Payables Non Current | - | $0 | $448,000 | $450,000 |
| Other Non Current Liabilities | - | - | $1,000 | $2,000 |
| Equity | ||||
| Common Stock Equity | $69,224,000 | $67,951,000 | $94,528,000 | $119,097,000 |
| Total Equity Gross Minority Interest | $69,224,000 | $67,951,000 | $94,528,000 | $119,097,000 |
| Stockholders Equity | $69,224,000 | $67,951,000 | $94,528,000 | $119,097,000 |
| Gains Losses Not Affecting Retained Earnings | $347,000 | $996,000 | $-1,344,000 | $22,000 |
| Retained Earnings | $-390,570,000 | $-390,764,000 | $-361,269,000 | $-337,817,000 |
| Other Equity Interest | - | $-1,000 | $-1,000 | - |
| Other | ||||
| Ordinary Shares Number | $49,996,185 | $49,834,983 | $49,834,983 | $49,815,489 |
| Share Issued | $49,996,185 | $49,834,983 | $49,834,983 | $49,904,418 |
| Tangible Book Value | $21,225,000 | $19,189,000 | $50,571,000 | $118,923,000 |
| Invested Capital | $126,297,000 | $132,246,000 | $163,244,000 | $186,262,000 |
| Working Capital | $17,604,000 | $74,635,000 | $119,089,000 | $205,260,000 |
| Capital Lease Obligations | $5,060,000 | $5,884,000 | $6,559,000 | $7,069,000 |
| Total Capitalization | $70,861,000 | $125,396,000 | $159,196,000 | $185,164,000 |
| Foreign Currency Translation Adjustments | $347,000 | $996,000 | $-1,344,000 | $22,000 |
| Additional Paid In Capital | $446,948,000 | $445,261,000 | $444,683,000 | $444,438,000 |
| Capital Stock | $12,499,000 | $12,459,000 | $12,459,000 | $12,454,000 |
| Common Stock | $12,499,000 | $12,459,000 | $12,459,000 | $12,454,000 |
| Employee Benefits | $1,341,000 | $978,000 | $782,000 | $864,000 |
| Non Current Deferred Revenue | $0 | $3,755,000 | $9,706,000 | $25,821,000 |
| Long Term Capital Lease Obligation | $3,915,000 | $4,808,000 | $5,527,000 | $5,980,000 |
| Current Deferred Revenue | $0 | $11,692,000 | $14,479,000 | $14,298,000 |
| Current Capital Lease Obligation | $1,145,000 | $1,076,000 | $1,032,000 | $1,089,000 |
| Line Of Credit | $0 | $89,000 | $0 | - |
| Current Provisions | $40,000 | $40,000 | $61,000 | $313,000 |
| Investments And Advances | $1,884,000 | $2,819,000 | $4,914,000 | $3,133,000 |
| Available For Sale Securities | $1,425,000 | $2,348,000 | $4,914,000 | $3,133,000 |
| Net PPE | $7,596,000 | $7,872,000 | $8,210,000 | $9,015,000 |
| Accumulated Depreciation | $-12,773,000 | $-12,331,000 | $-12,584,000 | $-11,003,000 |
| Gross PPE | $20,369,000 | $20,203,000 | $20,794,000 | $20,018,000 |
| Construction In Progress | $0 | $0 | $0 | $0 |
| Other Properties | $5,186,000 | $5,295,000 | $6,466,000 | $6,320,000 |
| Machinery Furniture Equipment | $3,499,000 | $3,541,000 | $3,407,000 | $3,386,000 |
| Buildings And Improvements | $11,684,000 | $11,367,000 | $10,921,000 | $10,311,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Investments | - | $471,000 | - | - |
| Other Short Term Investments | - | $0 | $4,550,000 | $0 |
| Treasury Shares Number | - | - | - | $88,929 |
| Minority Interest | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $14,570,000 | $-57,917,000 | $-72,638,000 | $99,378,000 |
| Operating Activities | ||||
| Operating Cash Flow | $15,549,000 | $-55,429,000 | $-72,638,000 | $99,915,000 |
| Cash Flow From Continuing Operating Activities | $15,549,000 | $-55,428,000 | $-72,637,000 | $99,914,000 |
| Operating Gains Losses | $-56,000 | $-81,000 | $-16,000 | $420,000 |
| Investing Activities | ||||
| Capital Expenditure | $-979,000 | $-2,488,000 | - | $-537,000 |
| Investing Cash Flow | $-1,039,000 | $2,234,000 | $-46,266,000 | $-3,377,000 |
| Cash Flow From Continuing Investing Activities | $-1,039,000 | $2,234,000 | $-46,266,000 | $-3,376,000 |
| Net Other Investing Changes | - | - | - | $-1,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $61,000 | $0 | $5,000 | $27,972,000 |
| Financing Cash Flow | $-10,570,000 | $-5,098,000 | $-3,786,000 | $-8,916,000 |
| Cash Flow From Continuing Financing Activities | $-10,570,000 | $-5,097,000 | $-3,786,000 | $-8,916,000 |
| Net Other Financing Charges | $-348,000 | $-493,000 | $-2,043,000 | $-1,835,000 |
| Net Common Stock Issuance | $61,000 | $0 | $5,000 | $27,972,000 |
| Common Stock Issuance | $61,000 | $0 | $5,000 | $27,972,000 |
| Cash Dividends Paid | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-10,283,000 | $-4,694,000 | $-1,748,000 | $-50,323,000 |
| Issuance Of Debt | $0 | $89,000 | $0 | $15,270,000 |
| End Cash Position | $81,788,000 | $77,789,000 | $136,001,000 | $258,756,000 |
| Beginning Cash Position | $77,789,000 | $136,001,000 | $258,756,000 | $171,029,000 |
| Effect Of Exchange Rate Changes | $60,000 | $80,000 | $-66,000 | $105,000 |
| Changes In Cash | $3,939,000 | $-58,292,000 | $-122,689,000 | $87,622,000 |
| Net Issuance Payments Of Debt | $-10,283,000 | $-4,605,000 | $-1,748,000 | $-35,053,000 |
| Net Long Term Debt Issuance | $-10,283,000 | $-4,605,000 | $-1,748,000 | $-35,053,000 |
| Long Term Debt Payments | $-10,283,000 | $-4,694,000 | $-1,748,000 | $-50,323,000 |
| Long Term Debt Issuance | $0 | $89,000 | $0 | $15,270,000 |
| Net Investment Purchase And Sale | $-140,000 | $4,550,000 | $-5,012,000 | $-3,148,000 |
| Sale Of Investment | $0 | $4,562,000 | $0 | $0 |
| Purchase Of Investment | $-140,000 | $-12,000 | $-5,012,000 | $-3,148,000 |
| Net Business Purchase And Sale | $0 | $0 | $-41,525,000 | $0 |
| Purchase Of Business | $0 | $0 | $-41,525,000 | $0 |
| Net Intangibles Purchase And Sale | $0 | $-2,074,000 | $0 | $-126,000 |
| Purchase Of Intangibles | $0 | $-2,074,000 | $0 | $-126,000 |
| Net PPE Purchase And Sale | $-899,000 | $-242,000 | $271,000 | $-102,000 |
| Sale Of PPE | $80,000 | $172,000 | $271,000 | $309,000 |
| Purchase Of PPE | $-979,000 | $-414,000 | - | $-411,000 |
| Taxes Refund Paid | $-74,000 | $-465,000 | $-145,000 | $0 |
| Change In Working Capital | $8,434,000 | $-27,815,000 | $-54,791,000 | $59,679,000 |
| Change In Payables And Accrued Expense | $-15,531,000 | $-10,397,000 | $-46,226,000 | $55,335,000 |
| Change In Payable | $-15,531,000 | $-10,397,000 | $-46,226,000 | $55,335,000 |
| Change In Account Payable | $-15,531,000 | $-10,397,000 | $-46,226,000 | $55,335,000 |
| Change In Receivables | $23,965,000 | $-17,418,000 | $-8,565,000 | $4,344,000 |
| Changes In Account Receivables | $23,965,000 | $-17,418,000 | $-8,565,000 | $4,344,000 |
| Other Non Cash Items | $2,895,000 | $-394,000 | $4,251,000 | $-30,874,000 |
| Stock Based Compensation | $610,000 | $578,000 | $245,000 | $470,000 |
| Asset Impairment Charge | $169,000 | $-392,000 | $-179,000 | $-1,996,000 |
| Deferred Tax | $340,000 | $380,000 | $-116,000 | $2,215,000 |
| Deferred Income Tax | $340,000 | $380,000 | $-116,000 | $2,215,000 |
| Depreciation Amortization Depletion | $1,724,000 | $1,654,000 | $1,832,000 | $2,742,000 |
| Depreciation And Amortization | $1,724,000 | $1,654,000 | $1,832,000 | $2,742,000 |
| Gain Loss On Sale Of PPE | $-56,000 | $-81,000 | $-16,000 | $420,000 |
| Net Income From Continuing Operations | $1,507,000 | $-28,894,000 | $-23,719,000 | $67,259,000 |
| Interest Paid Cff | - | - | $-2,180,000 | $-2,109,000 |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
Fetched: 2026-02-02